Intragastric balloons were designed to be a less dangerous alternative to existing medical weight loss procedures.  “Lap bands,” gastric bypasses, and other existing options had a high incidence of side effects, and were even linked to a number of deaths from perforated stomachs.  Due to being noninvasive, the hope was that gastric balloons would not carry the same risk profile as these previous treatments.

Continue Reading: FDA Urges Careful Evaluation of Gastric Balloons